v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net loss $ (3,287,917) $ (3,932,659)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 5,428 5,429  
Stock-based compensation 101,068 118,634  
Foreign currency (gain) loss (7,711) 51,803  
Changes in operating assets and liabilities:      
Prepaid expenses and other current and noncurrent assets 181,777 181,044  
Accounts payable 32,525 (71,935)  
Accrued expenses 218,104 16,521  
Net cash used in operating activities (2,756,726) (3,631,163)  
Cash flows from financing activities:      
Proceeds from issuance of common stock 35,098,813 59,234  
Common stock issuance costs (474,664) (3,385)  
Net cash provided by financing activities 34,624,149 55,849  
Change in cash, cash equivalents and restricted cash 31,867,423 (3,575,314)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (348) 1,398  
Cash, cash equivalents and restricted cash-beginning of year 14,640,533 22,890,055 $ 22,890,055
Cash, cash equivalents and restricted cash-end of period 46,507,608 19,316,139 14,640,533
Reconciliation of cash, cash equivalents and restricted cash      
Cash and cash equivalents 46,466,202 19,275,721 14,599,347
Restricted cash 41,406 40,418 41,186
Total cash, cash equivalents and restricted cash 46,507,608 $ 19,316,139 $ 14,640,533
Non-cash investing and financing activities:      
Stock subscription receivable 499,999    
Unpaid common stock issuance costs $ 2,299,616